CTT Pharmaceutical Holdings, Inc. has filed its quarterly report for the third quarter of 2026, detailing significant developments in its financial performance. The report, filed on November 18, 2026, is crucial for understanding the company's current position within the pharmaceutical preparations industry.
Company Background
CTT Pharmaceutical Holdings, Inc. is a company incorporated in Florida, primarily engaged in the pharmaceutical preparations sector, classified under SIC code 2834. The company trades on the OTC exchange under the ticker symbol CTTH. Recent filings include a 10-Q report on November 18, 2026, and a notification for a 10-Q filing on November 17, 2026.
What the Filing Says
The recent filing highlights that as of September 30, 2026, CTT Pharmaceutical Holdings had 61,516,676 shares outstanding, an increase from 58,837,232 shares reported at the end of 2025. The filing also indicates that the company issued 1,150,000 shares for services to key members, valued at $112,000 each. This suggests a strategic approach to incentivizing personnel and potentially enhancing operational capabilities.
Impact
This update may affect various stakeholders, including shareholders, employees, and competitors within the pharmaceutical preparations industry. The increase in shares outstanding and the issuance of stock for services could signal growth prospects and a focus on talent retention and acquisition.
What's Next
The filing does not specify what happens next for CTT Pharmaceutical Holdings, leaving investors and analysts to speculate on future strategies and developments.
Read Next
Madison Technologies reports Q3 results with net loss
Cyberloq Technologies Releases Q3 Results Amid Challenges
Specificity, Inc. Reports Q3 2026 Financial Results
SUNation Energy reports Q3 2026 financial results
Vystar Corp reports on Q3 performance in latest filing
Alpex Acquisition Corp Reports Quarterly Results










